Citation: U. Brinkmann et al., Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy, DRUG DISC T, 6(16), 2001, pp. 835-839
Authors:
Wellmann, A
Flemming, P
Behrens, P
Wuppermann, K
Lang, H
Oldhafer, K
Pastan, I
Brinkmann, U
Citation: A. Wellmann et al., High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: Correlation with tumor progression, INT J MOL M, 7(5), 2001, pp. 489-494
Authors:
Gellner, K
Eiselt, R
Hustert, E
Arnold, H
Koch, I
Haberl, M
Deglmann, CJ
Burk, O
Buntefuss, D
Escher, S
Bishop, C
Koebe, HG
Brinkmann, U
Klenk, HP
Kleine, K
Meyer, UA
Wojnowski, L
Citation: K. Gellner et al., Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene, PHARMACOGEN, 11(2), 2001, pp. 111-121
Citation: U. Brinkmann et M. Seifert, "Face to interface" - The establishment of trust in the internet: The caseof e-auctions, Z SOZIOLOG, 30(1), 2001, pp. 23-47
Authors:
Stubenrauch, K
Gleiter, S
Brinkmann, U
Rudolph, R
Lilie, H
Citation: K. Stubenrauch et al., Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles, BIOCHEM J, 356, 2001, pp. 867-873
Authors:
Behrens, P
Brinkmann, U
Fogt, F
Wernert, N
Wellmann, A
Citation: P. Behrens et al., Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development, ANTICANC R, 21(4A), 2001, pp. 2413-2417
Authors:
Hustert, E
Zibat, A
Presecan-Siedel, E
Eiselt, R
Mueller, R
Fuss, C
Brehm, I
Brinkmann, U
Eichelbaum, M
Wojnowski, L
Burk, O
Citation: E. Hustert et al., Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4, DRUG META D, 29(11), 2001, pp. 1454-1459
Authors:
Cascorbi, I
Gerloff, T
Johne, A
Meisel, C
Hoffmeyer, S
Schwab, M
Schaeffeler, E
Eichelbaum, M
Brinkmann, U
Roots, I
Citation: I. Cascorbi et al., Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects, CLIN PHARM, 69(3), 2001, pp. 169-174
Authors:
Meisel, C
Roots, I
Cascorbi, I
Brinkmann, U
Brockmoller, J
Citation: C. Meisel et al., How to manage individualized drug therapy: Application of pharmacogenetic knowledge of drug metabolism and transport, CLIN CH L M, 38(9), 2000, pp. 869-876
Authors:
Sprenger, R
Schlagenhaufer, R
Kerb, R
Bruhn, C
Brockmoller, J
Roots, I
Brinkmann, U
Citation: R. Sprenger et al., Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodulargenotype-phenotype correlation, PHARMACOGEN, 10(6), 2000, pp. 557-565
Authors:
Yerushalmi, N
Brinkmann, U
Brinkmann, E
Pai, L
Pastan, I
Citation: N. Yerushalmi et al., Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes, CANC GENE T, 7(1), 2000, pp. 91-96
Authors:
Korabiowska, M
Brinck, U
Brinkmann, U
Berger, H
Ruschenburg, I
Droese, M
Citation: M. Korabiowska et al., Prognostic significance of newly defined ploidy related parameters in melanoma, ANTICANC R, 20(3A), 2000, pp. 1685-1690
Authors:
Hoffmeyer, S
Burk, O
von Richter, O
Arnold, HP
Brockmoller, J
Johne, A
Cascorbi, I
Gerloff, T
Roots, I
Eichelbaum, M
Brinkmann, U
Citation: S. Hoffmeyer et al., Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo, P NAS US, 97(7), 2000, pp. 3473-3478